Diseases, Conditions, Syndromes

Zerbaxa approved for hospital-acquired bacterial pneumonia

(HealthDay)—Zerbaxa (ceftolozane and tazobactam) has been approved for a new indication to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years ...

HIV & AIDS

CDC: HIV tests rare in medical settings among WVa drug users

Emergency departments and inpatient medical personnel rarely conducted HIV testing on intravenous drug users in a West Virginia county with one of the nation's highest spikes in such cases, according to a federal investigation ...

Psychology & Psychiatry

Antipsychotics accelerate patient sedation, study finds

(Medical Xpress)—A new study is shedding light on the use of sedative drugs in hospitals and has proven certain clinically used drug combinations to be faster and more effective in sedating highly aggressive patients in ...

Cardiology

New anti-clotting drug more effective than current treatment

A new and experimental anti-clotting drug, cangrelor, proved better than the commonly used clopidogrel and was significantly more effective at preventing blood clots in a large trial of patients who underwent coronary stent ...

Medications

FDA: Omontys injection pulled from market

(HealthDay)—Affymax Inc. of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited of Deerfield, Ill., have voluntarily recalled all lots of Omontys Injection, used to treat anemia in adult dialysis patients, following ...

Diseases, Conditions, Syndromes

Treatment for deadly yeast disease reduced to three days

(Medical Xpress)—Initial treatment for a brain infection caused by fungus could now be treated in three days, rather than two weeks, due to study by University of Liverpool scientists.

page 5 from 7